{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:01:05Z","timestamp":1791302465448,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.intimp.2024.112195","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T05:16:33Z","timestamp":1717046193000},"page":"112195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["The ROCK inhibitor netarsudil in the treatment of corneal endothelial decompensation caused by corneal endotheliitis: A case report and literature review"],"prefix":"10.1016","volume":"136","author":[{"given":"Shang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijing","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Jie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.intimp.2024.112195_b0005","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/eye.1990.53","article-title":"The corneal endothelium","volume":"4","author":"Tuft","year":"1990","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.intimp.2024.112195_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108068","article-title":"12. Endothelial pump and barrier function","volume":"198","author":"Klyce","year":"2020","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.intimp.2024.112195_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108193","article-title":"Bicarbonate activates glycolysis and lactate production in corneal endothelial cells by increased ph(i)","volume":"199","author":"Li","year":"2020","journal-title":"Exp. Eye Res."},{"issue":"15","key":"10.1016\/j.intimp.2024.112195_b0020","doi-asserted-by":"crossref","first-page":"6843","DOI":"10.1167\/iovs.16-20123","article-title":"Activation of the rho\/rho kinase signaling pathway is involved in cell death of corneal endothelium","volume":"57","author":"Okumura","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2024.112195_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-9394(82)90693-6","article-title":"Clinical investigations on the corneal endothelium-xxxviii Edward Jackson memorial lecture","volume":"93","author":"Mishima","year":"1982","journal-title":"Am. J. Ophthalmol."},{"issue":"5","key":"10.1016\/j.intimp.2024.112195_b0030","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1167\/iovs.05-1139","article-title":"The balance between corneal transparency and edema: the proctor lecture","volume":"47","author":"Edelhauser","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2024.112195_b0035","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jamaophthalmol.2015.4776","article-title":"Global survey of corneal transplantation and eye banking","volume":"134","author":"Gain","year":"2016","journal-title":"Jama Ophthalmol"},{"issue":"9827","key":"10.1016\/j.intimp.2024.112195_b0040","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0140-6736(12)60437-1","article-title":"Corneal transplantation","volume":"379","author":"Tan","year":"2012","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.intimp.2024.112195_b0045","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/0002-9394(82)90466-4","article-title":"Presumed autoimmune corneal endotheliopathy","volume":"93","author":"Khodadoust","year":"1982","journal-title":"Am. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112195_b0050","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s40123-019-0169-7","article-title":"A review of corneal endotheliitis and endotheliopathy: differential diagnosis, evaluation, and treatment","volume":"8","author":"Moshirfar","year":"2019","journal-title":"Ophthalmol Ther"},{"issue":"4","key":"10.1016\/j.intimp.2024.112195_b0055","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/08820530802111010","article-title":"Corneal endotheliitis","volume":"23","author":"Suzuki","year":"2008","journal-title":"Semin. Ophthalmol."},{"issue":"9","key":"10.1016\/j.intimp.2024.112195_b0060","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/nrm2476","article-title":"Mammalian rho gtpases: new insights into their functions from in vivo studies","volume":"9","author":"Heasman","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112195_b0065","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/1878-0261.12019","article-title":"Modes of invasion during tumour dissemination","volume":"11","author":"Pandya","year":"2017","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.intimp.2024.112195_b0070","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ceb.2017.06.006","article-title":"Actomyosin contractility and collective migration: may the force be with you","volume":"48","author":"Pandya","year":"2017","journal-title":"Curr. Opin. Cell Biol."},{"issue":"4","key":"10.1016\/j.intimp.2024.112195_b0075","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1124\/pr.115.010595","article-title":"Rho kinases in health and disease: from basic science to translational research","volume":"67","author":"Loirand","year":"2015","journal-title":"Pharmacol. Rev."},{"issue":"6","key":"10.1016\/j.intimp.2024.112195_b0080","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nrm1128","article-title":"Rocks: multifunctional kinases in cell behaviour","volume":"4","author":"Riento","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.intimp.2024.112195_b0085","article-title":"Rock inhibitors for the treatment of ocular diseases","author":"Nourinia","year":"2017","journal-title":"Br. J. Ophthalmol."},{"issue":"6","key":"10.1016\/j.intimp.2024.112195_b0090","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1021\/acs.jmedchem.5b00683","article-title":"Rho kinase (rock) inhibitors and their therapeutic potential","volume":"59","author":"Feng","year":"2016","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.intimp.2024.112195_b0095","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2217\/fca.11.51","article-title":"Rho kinase as a therapeutic target in cardiovascular disease","volume":"7","author":"Surma","year":"2011","journal-title":"Future Cardiol."},{"key":"10.1016\/j.intimp.2024.112195_b0100","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3389\/fphar.2015.00276","article-title":"The function of rho-associated kinases rock1 and rock2 in the pathogenesis of cardiovascular disease","volume":"6","author":"Hartmann","year":"2015","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2024.112195_b0105","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00005-015-0382-6","article-title":"Novel insights into the roles of rho kinase in cancer","volume":"64","author":"Wei","year":"2016","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"key":"10.1016\/j.intimp.2024.112195_b0110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.exer.2016.08.023","article-title":"Role of the rho gtpase\/rho kinase signaling pathway in pathogenesis and treatment of glaucoma: bench to bedside research","volume":"158","author":"Rao","year":"2017","journal-title":"Exp. Eye Res."},{"issue":"2","key":"10.1016\/j.intimp.2024.112195_b0115","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.drudis.2019.11.017","article-title":"Rock-2-selective targeting and its therapeutic outcomes","volume":"25","author":"Sharma","year":"2020","journal-title":"Drug Discov. Today"},{"issue":"9","key":"10.1016\/j.intimp.2024.112195_b0120","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1002\/j.1460-2075.1996.tb00574.x","article-title":"Rho-associated kinase, a novel serine\/threonine kinase, as a putative target for small gtp binding protein rho","volume":"15","author":"Matsui","year":"1996","journal-title":"EMBO J."},{"issue":"18","key":"10.1016\/j.intimp.2024.112195_b0125","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1007\/s40265-014-0333-2","article-title":"Ripasudil: first global approval","volume":"74","author":"Garnock-Jones","year":"2014","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.intimp.2024.112195_b0130","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41433-019-0671-0","article-title":"New glaucoma medications: latanoprostene bunod, netarsudil, and fixed combination netarsudil-latanoprost","volume":"34","author":"Mehran","year":"2020","journal-title":"Eye (Lond.)"},{"issue":"17","key":"10.1016\/j.intimp.2024.112195_b0135","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1200\/JCO.20.02754","article-title":"Rock2 inhibition with belumosudil (kd025) for the treatment of chronic graft-versus-host disease","volume":"39","author":"Jagasia","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"22","key":"10.1016\/j.intimp.2024.112195_b0140","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1182\/blood.2021012021","article-title":"Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the rockstar study","volume":"138","author":"Cutler","year":"2021","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.intimp.2024.112195_b0145","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1016\/j.bmcl.2014.09.002","article-title":"Novel rock inhibitors for the treatment of pulmonary arterial hypertension","volume":"24","author":"Shaw","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.intimp.2024.112195_b0150","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/13543776.2017.1272579","article-title":"Rho kinase inhibitors: a patent review (2014\u20132016)","volume":"27","author":"Defert","year":"2017","journal-title":"Expert Opin. Ther. Pat."},{"issue":"5","key":"10.1016\/j.intimp.2024.112195_b0155","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1080\/02713683.2016.1250276","article-title":"Time course of conjunctival hyperemia induced by a rho-kinase inhibitor anti-glaucoma eye drop: ripasudil 0.4","volume":"42","author":"Terao","year":"2017","journal-title":"Curr. Eye Res."},{"issue":"1","key":"10.1016\/j.intimp.2024.112195_b0160","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1152\/physrev.00003.2012","article-title":"Regulation of small gtpases by gefs, gaps, and gdis","volume":"93","author":"Cherfils","year":"2013","journal-title":"Physiol. Rev."},{"issue":"2","key":"10.1016\/j.intimp.2024.112195_b0165","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10384-018-0566-9","article-title":"Impact of the clinical use of rock inhibitor on the pathogenesis and treatment of glaucoma","volume":"62","author":"Honjo","year":"2018","journal-title":"Jpn. J. Ophthalmol."},{"issue":"11","key":"10.1016\/j.intimp.2024.112195_b0170","doi-asserted-by":"crossref","first-page":"5447","DOI":"10.7150\/thno.54525","article-title":"Harnessing the tunable cavity of nanoceria for enhancing y-27632-mediated alleviation of ocular hypertension","volume":"11","author":"Luo","year":"2021","journal-title":"Theranostics"},{"issue":"7","key":"10.1016\/j.intimp.2024.112195_b0175","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/jcp.24524","article-title":"Regulation of plasticity and fibrogenic activity of trabecular meshwork cells by rho gtpase signaling","volume":"229","author":"Pattabiraman","year":"2014","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.intimp.2024.112195_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2013.05.002","article-title":"Rho-associated kinase inhibitors: a novel glaucoma therapy","volume":"37","author":"Inoue","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"issue":"6","key":"10.1016\/j.intimp.2024.112195_b0185","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/ICO.0000000000001209","article-title":"Descemetorhexis without grafting for fuchs endothelial dystrophy-supplementation with topical ripasudil","volume":"36","author":"Moloney","year":"2017","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.intimp.2024.112195_b0190","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1167\/iovs.13-12225","article-title":"Involvement of cyclin d and p27 in cell proliferation mediated by rock inhibitors y-27632 and y-39983 during corneal endothelium wound healing","volume":"55","author":"Okumura","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2024.112195_b0195","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1167\/iovs.15-18586","article-title":"Effect of the rho-associated kinase inhibitor eye drop (ripasudil) on corneal endothelial wound healing","volume":"57","author":"Okumura","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.intimp.2024.112195_b0200","doi-asserted-by":"crossref","DOI":"10.1089\/jop.2018.0063","article-title":"Assessing the effects of ripasudil, a novel rho kinase inhibitor, on human corneal endothelial cell health","author":"Goldstein","year":"2018","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"15","key":"10.1016\/j.intimp.2024.112195_b0205","doi-asserted-by":"crossref","first-page":"6731","DOI":"10.1167\/iovs.16-20414","article-title":"Corneal endothelial cell migration and proliferation enhanced by rho kinase (rock) inhibitors in in vitro and in vivo models","volume":"57","author":"Meekins","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.intimp.2024.112195_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110017","article-title":"Comparative transcriptome profile of mouse macrophages treated with the rhoa\/rock pathway inhibitors y27632, fingolimod (gilenya), and rezurock (belumosudil, slx-2119)","volume":"118","author":"Subuddhi","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.112195_b0215","doi-asserted-by":"crossref","first-page":"9167","DOI":"10.1038\/srep09167","article-title":"The effects of rho-associated kinase inhibitor y-27632 on primary human corneal endothelial cells propagated using a dual media approach","volume":"5","author":"Peh","year":"2015","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.intimp.2024.112195_b0220","doi-asserted-by":"crossref","first-page":"e62095","DOI":"10.1371\/journal.pone.0062095","article-title":"Rock inhibitor enhances adhesion and wound healing of human corneal endothelial cells","volume":"8","author":"Pipparelli","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2024.112195_b0225","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ajo.2020.12.006","article-title":"Potential functional restoration of corneal endothelial cells in fuchs endothelial corneal dystrophy by rock inhibitor (ripasudil)","volume":"224","author":"Schl\u00f6tzer-Schrehardt","year":"2021","journal-title":"Am. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.intimp.2024.112195_b0230","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1167\/tvst.10.4.18","article-title":"The rock inhibitor ripasudil shows an endothelial protective effect in patients with low corneal endothelial cell density after cataract surgery","volume":"10","author":"Fujimoto","year":"2021","journal-title":"Transl. Vis. Sci. Technol."},{"issue":"4","key":"10.1016\/j.intimp.2024.112195_b0235","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/s41433-021-01520-2","article-title":"Transcorneal freezing and topical rho-kinase inhibitor treatment in fuchs endothelial corneal dystrophy","volume":"36","author":"Menzel-Severing","year":"2022","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.intimp.2024.112195_b0240","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ajo.2021.03.006","article-title":"Randomized, double-masked pilot study of netarsudil 0.02% ophthalmic solution for treatment of corneal edema in fuchs dystrophy","volume":"227","author":"Price","year":"2021","journal-title":"Am. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112195_b0245","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/eye.2011.327","article-title":"Cytomegalovirus and the eye","volume":"26","author":"Carmichael","year":"2012","journal-title":"Eye (Lond.)"},{"issue":"1","key":"10.1016\/j.intimp.2024.112195_b0250","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.sjopt.2011.10.001","article-title":"Cytomegalovirus-related corneal endotheliitis: a review article","volume":"27","author":"Alfawaz","year":"2013","journal-title":"Saudi J. Ophthalmol."},{"issue":"Suppl 11","key":"10.1016\/j.intimp.2024.112195_b0255","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/ICO.0000000000000228","article-title":"Review of clinical and basic approaches to corneal endotheliitis","volume":"33","author":"Inoue","year":"2014","journal-title":"Cornea"},{"issue":"12","key":"10.1016\/j.intimp.2024.112195_b0260","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1007\/s00417-018-4111-9","article-title":"Diagnostic efficacy of real-time pcr for ocular cytomegalovirus infections","volume":"256","author":"Miyazaki","year":"2018","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112195_b0265","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/09273948.2017.1411952","article-title":"Diagnosis of cytomegalovirus anterior uveitis in two European referral centers","volume":"26","author":"Relvas","year":"2018","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"1","key":"10.1016\/j.intimp.2024.112195_b0270","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s10384-012-0189-5","article-title":"Mapping owl's eye cells of patients with cytomegalovirus corneal endotheliitis using in vivo laser confocal microscopy","volume":"57","author":"Yokogawa","year":"2013","journal-title":"Jpn. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112195_b0275","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ajo.2011.07.026","article-title":"Clinical significance of owl eye morphologic features by in vivo laser confocal microscopy in patients with cytomegalovirus corneal endotheliitis","volume":"153","author":"Kobayashi","year":"2012","journal-title":"Am. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.intimp.2024.112195_b0280","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ajo.2006.11.026","article-title":"Demonstration of \u201cowl's eye\u201d morphology by confocal microscopy in a patient with presumed cytomegalovirus corneal endotheliitis","volume":"143","author":"Shiraishi","year":"2007","journal-title":"Am. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112195_b0285","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1080\/09273948.2019.1678648","article-title":"Characteristics of corneal endotheliitis among different viruses by in vivo confocal microscopy","volume":"29","author":"Peng","year":"2021","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"1","key":"10.1016\/j.intimp.2024.112195_b0290","doi-asserted-by":"crossref","first-page":"5468","DOI":"10.1038\/s41598-018-23861-x","article-title":"A porcine ex vivo model of pigmentary glaucoma","volume":"8","author":"Dang","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2024.112195_b0295","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00417-018-4175-6","article-title":"Rki-1447, a rho kinase inhibitor, causes ocular hypotension, actin stress fiber disruption, and increased phagocytosis","volume":"257","author":"Dang","year":"2019","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"10","key":"10.1016\/j.intimp.2024.112195_b0300","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1167\/tvst.9.10.27","article-title":"Ripasudil in a model of pigmentary glaucoma","volume":"9","author":"Wang","year":"2020","journal-title":"Transl. Vis. Sci. Technol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924007136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924007136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:36:48Z","timestamp":1791301008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924007136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":60,"alternative-id":["S1567576924007136"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112195","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The ROCK inhibitor netarsudil in the treatment of corneal endothelial decompensation caused by corneal endotheliitis: A case report and literature review","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112195","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112195"}}